Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer

Journal of Nuclear Medicine

Volumn 48, Issue 6, 2007, Pages 879-888

  Handkiewicz Junak, Daria ^a   Wloch, Jan ^a   Roskosz, Jozef ^a   Krajewska, Jolanta ^a   Kropinska, Aleksandra ^a   Pomorski, Lech ^b   Kukulska, Aleksandra ^a   Prokurat, Andrzej ^c   Wygoda, Zbigniew ^a   Jarzab, Barbara ^a,d  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d NONE   (Poland)

Author keywords

Children; Differentiated thyroid cancer; Radioiodine; Recurrence; Therapy

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RECURRENCE RISK; RETROSPECTIVE STUDY; THYROID CANCER; THYROIDECTOMY; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADOLESCENT; CARCINOMA, PAPILLARY, FOLLICULAR; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPH NODES; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RISK; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 34250316484     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.035535     Document Type: Article

References (40)

1. Haugen BR. Initial treatment of differentiated thyroid carcinoma. Rev Endocr Metab Disord. 2000:1:139-145.
2. Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer. 2002:9:227-247.
3. Ringel MD, Levine MA. Current therapy for childhood thyroid cancer: optimal surgery and the legacy of king pyrrhus. Ann Surg Oncol. 2003:10:4-6.
4. Hallwirth U, Flores J, Kaserer K, Niederle B. Differentiated thyroid cancer in children and adolescents: the importance of adequate surgery and review of literature. Eur J Pediatr Surg. 1999:9:359-363.
5. Landau D, Vini L, A'Hern R, Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer. 2000;36:214-220.
6. Jarzab B, Handkiewicz-Junak D, Wloch J, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med. 2000:27:833-841.
7. Grigsby PW, Galor A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer. 2002:95:724-729.
8. Haveman JW, van Tol KM, Rouwe CW, Piersdo A, Plukker JT. Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol. 2003;10:15-20.
9. La Quaglia MP, Corbally MT, Heller G, Exelby PR, Brennan MF. Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery. 1988;104:1149-1156.
10. Borson-Chazot F, Causeret S, Lifante JC, Augros M, Berger N, Peix JL. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg. 2004;28:1088-1092.
11. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002:26:879-885.
12. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer. 2005:12:773-803.
13. Vassilopoulou-Sellin R, Klein MJ, Smith TH, et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer. 1993;71:1348-1352.
14. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med. 1998:39:1531-1536.
15. Chow SM, Law SC, Mendenhall WM, et al. Differentiated thyroid carcinoma in childhood and adolescence: clinical course and role of radioiodine. Pediatr Blood Cancer. 2004;42:176-183.
16. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab. 2004;89:3668-3676.
17. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998;124:958-964.
18. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:1-34.
19. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006:154:787-803.
20. Kukulska A. Thyroglobulin as a Marker for Differentiated Thyroid Cancer. [MD thesis]. Zabrze, Poland: Medical University of Silesia; 1996.
21. Demidchik YE, Demidchik EP, Reiners C, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg. 2006;243:525-532.
22. Shapiro NL, Bhattacharyya N. Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope. 2005;115:337-340.
23. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Francis GL. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. J Pediatr Surg. 1999;34:1799-1804.
24. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis - a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg. 1998;227:533-541.
25. Patel A, Jhiang S, Dogra S, et al. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatr Res. 2002:52:737-744.
26. Faggiano A, Coulot J, Bellon N, et al. Age dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. J Nucl Med. 2004;45:232-237.
27. Schlumberger M, De Vathaire F, Travagli JP, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab. 1987;65:1088-1094.
28. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002;12:683-702.
29. Reynolds J. Comparison of I-131 absorbed radiation doses in children and adults: a tool for estimating therapeutic I-131 doses in children. In: Robbins J, ed. Treatment of Thyroid Cancer in Children. Washington, D.C.: U.S. Department of Energy and U.S. Department of Commerce: Technology, Administration. National Technical Information; 1993:127-135.
30. van Santen HM, Aronson DC, Vulsma T, et al. Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience. Eur J Cancer. 2004:40:1743-1751
31. Maxon HR. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med. 1999:43:313-323.
32. Salvesen H, Njolstad LA, Akslen LA, Albrektsen O, Soreide O, Varhaug JE. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg. 1992;158:583-589.
33. Robie D, Welch Dinauer CA, Tuttle RM, at al. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer. J Pediatr Surg. 1998;33:1134-1140.
34. 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab. 2006:91:60-63.
35. 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2005:90:1440-1445.
36. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol. 2000;35:41-46.
37. Kebebew E, Duh QY, Clark OH. Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. World J Surg. 2000;24:1295-1302.
38. Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer. 2003;89:1638-1644.
39. Schlumberger M, De Vathaire F, Ceccarelli C, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med. 1996;37:606-612
40. Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet. 2004;75:1131-1135.